Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice

Ritz, 1999, Nephropathy in patients with type 2 diabetes mellitus, N Engl J Med, 341, 1127, 10.1056/NEJM199910073411506 Mauer, 1984, Structural-functional relationships in diabetic nephropathy, J Clin Invest, 74, 1143, 10.1172/JCI111523 Ziyadeh, 1993, The extracellular matrix in diabetic nephropathy, Am J Kidney Dis, 22, 736, 10.1016/S0272-6386(12)80440-9 Park, 1997, Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes, Diabetes, 46, 473, 10.2337/diab.46.3.473 Yamamoto, 1993, Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy, Proc Natl Acad Sci USA, 90, 1814, 10.1073/pnas.90.5.1814 Ziyadeh, 2000, Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice, Proc Natl Acad Sci USA, 97, 8015, 10.1073/pnas.120055097 Wolf, 2005, From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy, Diabetes, 54, 1626, 10.2337/diabetes.54.6.1626 Pagtalunan, 1997, Podocyte loss and progressive glomerular injury in type II diabetes, J Clin Invest, 99, 342, 10.1172/JCI119163 Bradham, 1991, Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10, J Cell Biol, 114, 1285, 10.1083/jcb.114.6.1285 Brigstock, 2003, Proposal for a unified CCN nomenclature, Mol Pathol, 56, 127, 10.1136/mp.56.2.127 Perbal, 2004, CCN proteins: multifunctional signalling regulators, Lancet, 363, 62, 10.1016/S0140-6736(03)15172-0 Gupta, 2000, Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis, Kidney Int, 58, 1389, 10.1046/j.1523-1755.2000.00301.x Yokoi, 2002, Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis, Am J Physiol, 282, F933 Yokoi, 2001, Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: a potential target for preventing renal fibrosis, Am J Kidney Dis, 38, S134, 10.1053/ajkd.2001.27422 Holmes, 2001, CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling, J Biol Chem, 276, 10594, 10.1074/jbc.M010149200 Frazier, 1996, Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor, J Invest Dermatol, 107, 404, 10.1111/1523-1747.ep12363389 Duncan, 1999, Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP, FASEB J, 13, 1774, 10.1096/fasebj.13.13.1774 Yokoi, 2004, Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis, J Am Soc Nephrol, 15, 1430, 10.1097/01.ASN.0000130565.69170.85 Riser, 2000, Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis, J Am Soc Nephrol, 11, 25, 10.1681/ASN.V11125 Roestenberg, 2006, Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice, Am J Physiol, 290, F1344 Makino, 2003, Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment, Clin Exp Nephrol, 7, 33, 10.1007/s101570300004 Umezono, 2002, Localization of connective tissue growth factor mRNA in human diabetic nephropathy by in situ hybridization, Clin Exp Nephrol, 6, 13, 10.1007/s101570200002 Wahab, 2001, Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy, Biochem J, 359, 77, 10.1042/bj3590077 Ito, 1998, Expression of connective tissue growth factor in human renal fibrosis, Kidney Int, 53, 853, 10.1111/j.1523-1755.1998.00820.x McLennan, 2004, Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy, Endocrinology, 145, 5646, 10.1210/en.2004-0436 Wong, 2000, Identification and characterization of a glomerular-specific promoter from the human nephrin gene, Am J Physiol, 279, F1027 Eremina, 2003, Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases, J Clin Invest, 111, 707, 10.1172/JCI17423 Matsusaka, 2005, Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury, J Am Soc Nephrol, 16, 1013, 10.1681/ASN.2004080720 Suzuki, 2002, Renal in situ hybridization studies of extracellular matrix related molecules in type I diabetes mellitus, Nephron, 92, 564, 10.1159/000064110 Murphy, 1999, Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells, J Biol Chem, 274, 5830, 10.1074/jbc.274.9.5830 Twigg, 2002, Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine, Endocrinology, 143, 4907, 10.1210/en.2002-220619 Zhou, 2004, Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor β-independent pathway, Am J Pathol, 165, 2033, 10.1016/S0002-9440(10)63254-3 Andersen, 2005, Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy, Kidney Int, 67, 2325, 10.1111/j.1523-1755.2005.00337.x Guha, 2007, Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes, FASEB J, 21, 3355, 10.1096/fj.06-6713com Hoshi, 2002, Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats, Lab Invest, 82, 25, 10.1038/labinvest.3780392 Yoshikawa, 1986, Glomerular podocyte vacuolation in focal segmental glomerulosclerosis, Arch Pathol Lab Med, 110, 394 Toth, 1992, Glomerular podocyte vacuolation in idiopathic membranous glomerulonephritis, Nephron, 61, 16, 10.1159/000186828 Boute, 2000, NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome, Nat Genet, 24, 349, 10.1038/74166 Roselli, 2004, Early glomerular filtration defect and severe renal disease in podocin-deficient mice, Mol Cell Biol, 24, 550, 10.1128/MCB.24.2.550-560.2004 Moritani, 1994, Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice, Int Immunol, 6, 1927, 10.1093/intimm/6.12.1927 Ogawa, 1994, Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene, J Clin Invest, 93, 1911, 10.1172/JCI117182 Makino, 2002, Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist, J Am Soc Nephrol, 13, 1757, 10.1097/01.ASN.0000019782.37851.BF Suganami, 2001, Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury, J Am Soc Nephrol, 12, 2652, 10.1681/ASN.V12122652 Koshikawa, 2005, Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome, J Am Soc Nephrol, 16, 2690, 10.1681/ASN.2004121084 Sawai, 2006, Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy, Nephrol Dial Transplant, 21, 2472, 10.1093/ndt/gfl260 Nakanishi, 2005, Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice, Hypertension, 46, 441, 10.1161/01.HYP.0000173420.31354.ef Bonniaud, 2004, Connective tissue growth factor is crucial to inducing a profibrotic environment in ‘fibrosis-resistant’ Balb/c mouse lungs, Am J Respir Cell Mol Biol, 31, 510, 10.1165/rcmb.2004-0158OC Suganami, 2005, Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy, FASEB J, 19, 127, 10.1096/fj.04-2183fje Kawakami, 2004, Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction, Circulation, 110, 3306, 10.1161/01.CIR.0000147829.78357.C5